V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002514 | 240007151 | 1.57 | 96.4 | null | 2021-05-13 | 2021-05-16 | IMATINIB | 02 | Y | CNS HGG TEMOZOLOMIDE +XRT | 100020626 |
| 240002518 | 240007152 | 1.68 | 112.9 | 03 | null | 2019-04-29 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | BENDAMUSTINE + OBINUTUZUMAB | 101274491 |
| 240002519 | 240007153 | 1.62 | 90.6 | 03 | 2018-02-16 | 2018-02-26 | PEG INTERFERON | 02 | N | METHOTREXATE INTRATHECAL | 101262604 |
| 240002522 | 240007155 | 1.67 | 68.2 | Curative (C) | 2017-06-29 | 2017-07-01 | Cladribine (subcut) 5 days | 02 | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100113108 |
| 240002524 | 240007156 | 1.7 | 10.75 | Curative (C) | 2019-03-10 | 2019-03-15 | AML Interim Guidelines FLAG-Ida | 02 | N | PEG INTERFERON | 101135328 |
| 240002527 | 240007158 | 1.65 | 66.3 | null | null | 2020-03-18 | AML Downs ADE 10+3+5 (1)redcd Dauno | 01 | null | TRANSPLANT ALEMTUZUMAB + CYCLOPHOSPHAMIDE (+/- TBI) | 101474928 |
| 240002528 | 240007159 | 1.75 | 63.6 | null | null | 2016-08-05 | null | null | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101529663 |
| 240002530 | 240007161 | null | 66 | Curative (C) | 2016-03-18 | 2016-03-26 | null | 02 | N | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 101456655 |
| 240002532 | 240007163 | 1.75 | 87.5 | Curative (C) | null | 2019-03-14 | Cytarabine High Dose | null | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + VINCRISTINE | 100335586 |
| 240002533 | 240007164 | 1.61 | 66.7 | Curative (C) | 2017-04-25 | 2017-04-25 | Bendamustine + Obinutuzumab | 02 | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100183101 |
| 240002535 | 240007165 | null | 70.3 | Adjuvant (A) | null | 2017-07-17 | FLUDARABINE + MELPHALAN | null | N | CYTARABINE HIGH DOSE | 101139453 |
| 240002536 | 240007166 | 1.57 | 72.2 | Palliative (P) | 2016-05-04 | 2016-06-21 | null | 01 | N | FLUDARABINE + MELPHALAN | 100869746 |
| 240002537 | 240007167 | 1.55 | 71.5 | null | 2019-03-12 | 2019-03-16 | Brentuximab Vedotin | 02 | null | TRIPLE INTRATHECAL | 101641673 |
| 240002538 | 240007168 | 1.75 | 66.3 | Curative (C) | 2017-07-28 | 2017-07-28 | AML MyeChild 01 FLA | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100878630 |
| 240002539 | 240007169 | null | 66 | Curative (C) | 2018-05-14 | 2018-05-21 | VINCRISTINE | 02 | N | ALL UKALL2011 AUG BFM CONS C | 100615225 |
| 240002540 | 240007170 | 1.7 | 79.1 | 03 | 2021-04-05 | 2021-04-05 | null | 02 | N | CYTARABINE HIGH DOSE | 101825739 |
| 240002546 | 240007174 | 1.68 | 77 | null | 2019-02-21 | 2019-04-02 | ABVD | 02 | null | IVOSIDENIB | 100372532 |
| 240002548 | 240007175 | 1.62 | 0 | null | 2018-02-23 | 2018-02-23 | null | 02 | null | THALIDOMIDE | 101115927 |
| 240002553 | 240007177 | null | 49.6 | Curative (C) | null | 2017-04-24 | DA-EPOCH-R | null | N | AZACITIDINE + VENETOCLAX | 100040788 |
| 240002555 | 240007178 | 1.64 | 80.8 | null | null | 2019-07-26 | R GCVP | null | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100371230 |
| 240002556 | 240007179 | 1.71 | 80.5 | null | 2019-06-17 | 2019-09-16 | LCHIV IC-2 | 02 | null | RUXOLITINIB | 100977846 |
| 240002557 | 240007180 | 1.52 | 53.9 | 03 | 2016-06-22 | 2016-06-22 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 01 | N | CYTARABINE HIGH DOSE | 101559226 |
| 240002561 | 240007183 | 1.79 | 55 | Curative (C) | 2021-07-09 | 2021-07-31 | DA 3+8 | 01 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101126037 |
| 240002562 | 240007184 | 1.75 | 71.4 | null | 2019-06-11 | 2019-06-11 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | 02 | null | METHOTREXATE INTRATHECAL | 100461868 |
| 240002563 | 240007185 | 1.77 | 72.9 | 03 | 2018-05-01 | 2018-05-09 | GEMTUZUMAB OZOGAMICIN | 02 | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100236291 |
| 240002565 | 240007186 | 1.02 | 10.8 | 03 | 2018-08-11 | 2018-08-19 | null | 02 | null | ALL UKALL2011 IND B | 100932525 |
| 240002569 | 240007188 | 1.57 | 86 | 03 | 2018-09-01 | 2019-01-31 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100645679 |
| 240002571 | 240007189 | 1.65 | 84.5 | Curative (C) | 2020-10-20 | 2020-10-20 | R CODOX M | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101140289 |
| 240002572 | 240007190 | 1.63 | 112.5 | null | 2018-11-06 | 2018-11-16 | AML MyeChild 01 Arm E MAC HSCT | 02 | null | RITUXIMAB + VENETOCLAX | 101846845 |
| 240002573 | 240007191 | 1.77 | 84.4 | Curative (C) | 2020-11-26 | 2020-11-26 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | null | ALL UKALL2011 STD BFM CONS B | 100651140 |
| 240002574 | 240007192 | 1.66 | null | Palliative (P) | null | 2019-08-02 | FLAG + Idarubicin | 02 | N | RUXOLITINIB | 100213468 |
| 240002576 | 240007193 | 1.67 | 10 | null | 2020-05-29 | 2020-05-29 | GDP | N | null | BUSULFAN | 100397262 |
| 240002577 | 240007194 | null | 91.6 | Curative (C) | 2016-12-13 | 2017-01-07 | AML MyeChild 01 A Mitozantrone/Cytarabine | 01 | null | DHAP | 101309020 |
| 240002578 | 240007195 | 1.58 | 54.1 | Curative (C) | 2019-09-13 | 2019-09-13 | null | null | N | CYTARABINE + DAUNORUBICIN | 101858176 |
| 240002579 | 240007196 | 1.71 | 65 | Curative (C) | 2016-12-06 | 2016-12-23 | null | 01 | N | RUXOLITINIB | 100466372 |
| 240002580 | 240007197 | 1.79 | 131 | Curative (C) | null | 2020-08-23 | Cytarabine High Dose | null | null | OBINUTUZUMAB + VENETOCLAX | 100624205 |
| 240002589 | 240007201 | 1.91 | 69 | null | null | 2017-06-08 | AML MyeChild 01 A Mitozantrone/Cytarabine | 01 | null | CLADRIBINE | 101149306 |
| 240002590 | 240007202 | 1.7 | 73.6 | Curative (C) | 2021-06-28 | 2021-09-02 | null | 02 | null | AML 18 PILOT TRIAL | 100767640 |
| 240002594 | 240007204 | 1.69 | 84.4 | Curative (C) | 2022-01-30 | 2022-02-03 | ALL UKALL2011 Cap Int Maint C PAsp | 01 | null | BUSULFAN | 101676444 |
| 240002598 | 240007207 | 1.64 | 62.8 | 03 | 2017-12-05 | 2017-12-20 | null | 02 | null | CYTARABINE + GEMTUZUMAB OZOGAMICIN | 101400535 |
| 240002600 | 240007208 | 1.78 | 8.9 | null | 2019-01-06 | 2019-06-08 | AML Downs HA | 02 | null | METHOTREXATE + VINBLASTINE | 101511422 |
| 240002604 | 240007209 | 1.84 | 77.75 | Curative (C) | null | 2017-11-09 | CYTARABINE + MITOXANTRONE | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100898534 |
| 240002606 | 240007210 | 1.6 | 99.7 | Curative (C) | 2016-12-24 | 2016-12-26 | BUSULFAN | 02 | N | METHOTREXATE INTRATHECAL | 100147441 |
| 240002612 | 240007212 | 1.7 | 72.6 | null | 2020-11-29 | 2020-11-29 | null | 02 | null | RUXOLITINIB | 100396553 |
| 240002613 | 240007213 | 1.43 | 86.95 | Curative (C) | 2016-04-03 | 2016-04-22 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | 02 | N | INTERFERON ALFA | 101654756 |
| 240002616 | 240007214 | 1.65 | 87.4 | null | 2018-07-22 | 2018-07-29 | null | null | N | IMATINIB | 100620403 |
| 240002617 | 240007215 | 1.58 | 75 | null | 2019-11-02 | 2019-11-02 | null | 02 | N | CARBOPLATIN + VINCRISTINE | 100211687 |
| 240002619 | 240007217 | 1.73 | null | Curative (C) | 2019-04-14 | 2019-04-17 | null | 02 | N | IDELALISIB + RITUXIMAB | 101456528 |
| 240002620 | 240007218 | 1.58 | 65.8 | Curative (C) | 2019-05-12 | 2019-05-18 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100852396 |
| 240002623 | 240007220 | 1.7 | 17.15 | Curative (C) | null | 2020-01-20 | PEG INTERFERON | null | N | BUSULFAN | 101568772 |